Listen

Description

Naloxone and nalmefene are reaching more hands than ever—through bystander programs, pharmacy dispensing protocols, and over-the-counter sales. But as access expands, one question keeps coming up:

Does easier access to naloxone or nalmefene actually make opioid misuse worse?

In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about whether increasing naloxone and nalmefene access encourages opioid misuse or overdose. Hosts Don Weinberger, PharmD, and Steve Small, PharmD, bring in addiction medicine specialist Dr. Nicole Gastala, MD, to unpack what the evidence actually shows.

Together, they discuss:

No CE credit is available for this bonus episode.
Want the full breakdown? CE credit is available for our full episode on opioids.

******

🎧 Related Episode (CE Available)

******

TRC Healthcare Editor Hosts

Guest

******

Clinical Resources: 

🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout. 

******

🗪 Send us Fan Mail

Email us: rumorvstruth@trchealthcare.com

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.